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ABSTRACT: A chemoenzymatic cascade process for the sustainable production of pyrroles has 
been developed. Pyrroles were synthesised exploiting the previously unexplored aromatizing 
activity of monoamine oxidase enzymes (MAO-N and 6-HDNO). MAO-N/6-HDNO whole cell 
biocatalysts are able to convert 3-pyrrolines into pyrroles under mild conditions and high yields. 
Moreover, MAO-N can work in combination with ruthenium Grubbs' catalyst leading to the 
synthesis of pyrroles from diallyl-amines/anilines in a one-pot cascade metathesis-aromatization 
sequence. 
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INTRODUCTION 
The occurrence of aromatic nitrogen heterocycles in many natural and synthetic biologically 
active compounds represents an incentive toward the development of new synthetic 
methodologies toward these important chemicals.1 It is estimated that more of 50% of the 
bestselling drugs contain a nitrogen heterocyclic nucleus, thus fueling a demand for broadly 
applicable synthetic methods that deliver aromatic heterocycles in high yield. We recently 
discovered a new class of pyrroles endowed with potent activity against drug-resistant 
tuberculosis and thus we became interested in finding new sustainable approaches for the 
production of this class of compounds.2 Typical approaches for the synthesis of pyrroles include 
the Paal−Knorr and Clauson−Kass reactions,3 the aza-Wittig reaction4 or other multicomponent 
approaches.5 Approaches to pyrroles under relatively mild conditions via iron or palladium 
catalysed Paal-Knorr reactions on water have been also described.6 However, the  structural 
features of the reagents required in the latter methods or the side products formed may represent 
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a limitation in the scope of these reactions. Recently, olefin ring-closing metathesis (RCM) 
emerged as a powerful and effective reaction for the two steps synthesis of many functionalized 
pyrroles from acyclic precursors. Donohoe7 and Rutjies8 first developed a two steps sequence to 
pyrroles from diallylamines 1 via ring-closing metathesis (RCM) followed by aromatization 
mediated by RuCl3, Pd/C, FeCl3 or 
tBuOOH (Figure 1). This latter step is supposed to occur 
through the oxidation of the amine 2 into the corresponding iminium intermediate 3 leading in 
turn to pyrrole 4 by tautomerization. The direct oxidation of amines into imines or iminium ions 
still represents a challenge in organic synthesis and only few approaches have been described so 
far. These methods rely on the use of metal catalysts such Fe, Pd, Ru in the presence of oxygen 
or TEMPO and often require harsh reaction conditions.9 However, in Nature, the conversion of 
an amine group into the corresponding imine is a common biochemical transformation that is 
catalysed by monoamine oxidase (MAO) enzymes.10 MAO enzymes catalyse the oxygen-
dependent oxidation of amines into imines which are in turn hydrolysed into aldehydes under 
aqueous conditions. Due to their unique properties, the monoamine oxidase variants from 
Aspergillus niger (MAO-N) have found a broad application also as biocatalysts for 
stereocontrolled syntheses11 and have been extensively used in a variety of synthetic 
transformations. In particular, MAO-N have been widely studied as biocatalysts for the 
production of enantiomerically pure amines through the selective oxidation and deracemization 
of a range of chiral aliphatic substrates.11 Herein, we describe a new sustainable approach for the 
synthesis of pyrroles unveiling for the first time the ability and versatility of MAO-N enzymes in 
catalysing the oxidation-aromatization of 3-pyrrolines 2 into pyrroles 4. In addition, a one-pot 
chemoenzymatic cascade reaction for the synthesis of pyrroles through the in-situ combination of 
RCM reactions with the MAO-N aromatizing biocatalysts is described.  
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RESULTS AND DISCUSSION 
The MAO-N aromatization of 3-pyrrolines substrates 7 and 10, synthesised via RCM as 
reported in Scheme 1,12 was first investigated. Freeze-dried whole cells containing MAO-N 
variants D5, D9 and D11 were selected on the basis on their known activity and selectivity 
toward structurally related pyrrolidines.11 In addition, the oxidizing/aromatizing properties of the 
recently developed nicotine oxidase biocatalyst 6-HDNO E350L/E352D13 were also explored. 
All the enzymatic biotransformations were initially carried out at 37 oC in a buffer solution (pH = 
7.8) using DMF as co-solvent where appropriate, according to standard protocols.11a The data are 
summarised in Table 1 and Table 2. The aryl-pyrrolines 7 were converted into pyrroles 11 with 
moderate to excellent yields depending on the substituent on the aryl group. The phenyl-
pyrroline 7a was converted into pyrrole 11a by MAO-D5 and 6-HDNO in good amount (61%), 
whilst the variant D9 led to 11a in only 32% conversion. Full conversion (>99%) of pyrrolines 
7d and the 2-methyl-substituted 7i was observed with MAO-D5, whilst D9 and 6-HDNO proved 
to be less active. On the other hand, no conversion of the pyrrolines 7j-k into pyrroles bearing a 
phenyl substituent at C2 and C3 respectively was observed. Steric factors prevented 7j-k to enter 
into the catalytic site of MAO-D5 as shown by docking simulation in Figure 2.14Docking 
simulations were carried out in order to show the interaction of pyrrolines 7a and 7k within the 
catalytic site of MAO-D5 and explain the experimental data. Whilst 7a fits within the catalytic 
site of MAO-D5, the phenyl substituent (in yellow) of the bulkier 7k lays in a region of the 
catalytic site where an amino acid residue is located, thus preventing 7k from entering the 
enzyme's active site and being aromatized. Again, no conversion was observed when 7j-k were 
treated with the variant MAO-D11.The substrates 7g and 7h bearing an electron withdrawing 
substituent on the aromatic ring (-NO2 and -CN respectively) were not converted into 
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corresponding pyrroles. Despite the exact mechanism of action of MAO has not fully 
elucidated,15 one of the proposed model suggests that the oxidation of amines proceeds through a 
nucleophilic mechanism where the amine attacks the FAD by nucleophilic addition and it is in 
turn oxidised to imine leading to the formation of the reduced FADH2.16 Thus, it is likely that the 
electron withdrawing substituents on the phenyl ring of 7g-h reduce the electronic density and 
consequently the nucleophilicity of the pyrroline nitrogen, thus preventing the attack of 7g-h to 
FAD and their following oxidation into pyrroles.17 As further confirmation of this assumption, 
the more nucleophilic alkyl pyrrolines 10a-f were fully converted (>99%) by MAO-D5. Table 2. 
Lower conversion (51-61%) values were observed when the same biotransformations were 
carried out with MAO-D9. The nicotine oxidase 6-HDNO was able to fully oxidise the benzyl-
pyrroline 10a (95%) while lower conversion (65%) was observed for the bulkier cyclohexyl 
derivative 10f. Pyrroline 10g bearing a bulky substituent on the nitrogen was oxidised in low 
yields as well as the benzyl pyrrolines 10h-i bearing two methyl substituents on the heterocyclic 
nucleus (48-51% of 12h-12i). Finally, the aromatization of 10j-k bearing a phenyl substituent on 
the pyrroline nucleus was investigated. Interestingly, the secondary pyrroline 9c was poorly 
converted into the pyrrole 12l by all the set of amino oxidase catalysts, whilst excellent 
conversion values were observed for the tertiary pyrroline 10j. Lower conversion for 10k was 
observed due to steric factors. 
One of the most intriguing challenge for chemists and biologists is represented by the 
possibility to combine chemo- and enzymatic catalysis in a concurrent fashion, due to the 
compatibility issues of the catalysts and the different reaction conditions in which these generally 
operate.18 The combination of chemo- and bio-catalysis offers opportunities to outperform 
sequential transformations and the development of one-pot multistep-cascade reactions 
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containing both transition-metal catalysts and enzymes is highly appealing in terms of both 
selectivity and synthetic efficiency. Moreover, cascade reactions offer additional benefits other 
than the immediate succession of the individual transformations, such as the almost 
instantaneous consumption of toxic or unstable intermediates without the requirement of 
intermediate isolation or functional group protection strategies, leading to safer processes and to 
the reduction of undesired side products. Thus, the combination of RCM reactions with MAO 
biocatalysts in the same reaction medium was investigated with the aim to develop a 
chemoenzymatic cascade synthesis of pyrroles from allyl-amines/anilines as shown in Table 3. 
The diallylaniline 6a was first dissolved in a 1:60 DMF/Buffer pH=7.8 solution and treated 
simultaneously with 5mol% Grubbs' catalyst GII and MAO-D5 at 37 oC. Aniline 6a was 
recovered from the reaction mixture after 24h and only 10% of 3-pyrroline 7a was obtained, 
whilst no traces of the pyrrole 11a were detected (entry 1). On the opposite, 90% of 7a was 
obtained when the same biotransformation was performed in 1:60 acetone/buffer mixture. Again 
no traces of 11a were observed (entry 2). It is known that acetone is a more suitable solvent for 
RCM reaction than DMF, thus accounting for the higher amount of 7a detected in the second 
case.19 Increasing the co-solvent/buffer ratio to 1:4 and using different water-miscible co-
solvents (THF and DMSO) (entries 4-7) did not affect the outcome of the biotransformation. In 
all cases, variable amounts of the RCM product 7a were detected but no traces of the desired 
pyrrole 11a were obtained. Previous works demonstrated that MAO biocatalysts suffer the co-
presence of chemocatalysts in the same reaction medium.11c Recently, Hartwig and Zhao showed 
that iso-octane can work as excellent co-solvent in chemoenzymatic biotransformations, due to 
its ability to form a biphasic system with low mass transfer together with the buffer solution.20,18a 
When the chemoenzymatic reaction was carried out in an iso-octane/buffer 1:4 mixture (entry 8), 
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the pyrrole 11a was obtained as main product in high yield together with negligible amount of 
7a.  The use of the non-water miscible co-solvent iso-octane proved to be crucial to prevent the 
interaction between the Ru-catalyst and the MAO-D5 and avoid the deactivation of the enzyme 
probably due to the Ru binding. In fact, in an immiscible iso-octane-buffer mixture, the 
homogeneous Ru-catalyst is partioned in the organic phase, while the biocatalyst is suspended in 
water. The diene 6a is converted by GII into the 3-pyrroline 7a in the iso-octane phase, and 
then7a is oxidized by MAO-D5 leading to the desired pyrrole 11a. The biphasic reaction 
medium acts mimicking the compartmentalization of cellular processes allowing thus the 
cascade reactions to take place in an efficient manner.  The scope of the chemoenzymatic 
cascade was then investigated as shown in Table 4. Pyrrole 11a was obtained in 88% conversion 
and 78% isolated yield (method A). With the aim to improve the yield of the reaction, a two 
steps method was also set up. Allylaniline 6a was mixed with GII and MAO-D5 and stirred at 37 
oC for 6 h, after which time an additional amount of MAO-D5 was added (method B). Higher 
conversion (95%) was observed with the one-pot two steps protocol, but 11a was isolated in 
lower yield (65%) (entry 2). It is noteworthy that the treatment of 7a with MAO-D5 led to 11a 
with 61% conversion, whilst the chemoenzymatic cascade led to 11a from 6a in 95% 
conversion.It is plausible that in the chemoenzymatic cascade the aniline 6a is converted into the 
pyrroline 7a slowly. As soon as 7a if formed, it is immediately oxidised by MAO-D5 affording 
11a. In this way only a low amount of 7a is oxidised by MAO-D5 time by time allowing a more 
rapid enzyme turnover. Similarly, pyrroles 11b and 11l (entries 5-6, 11-12) were isolated in high 
yields when the one-pot one-step method A was used whilst higher conversion values were 
observed with the two steps one-pot protocol B. As general trend, excellent conversion and high 
yields were observed for pyrroles bearing chloro- (11l), methyl-(11m) and alkoxy-substituents 
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(11n, 11o) (entries 11-17).  Medium to good conversion (50-75%) was observed for pyrroles 
11d-e (entries 6-8) probably due to the lower reactivity of electron-rich diallylanilines toward the 
RCM reaction. In fact, several factors must be taken into account in the chemoenzymatic 
cascade, such as the reactivity of anilines in the metathesis reaction, where electron donating 
substituents on the phenyl ring disfavour the ring closure, as well as the biocatalytic oxidation, 
where electron withdrawing substituents prevent the pyrroline oxidation.  
The chemoenzymatic cascade of alkyl-diallylamines was finally investigated. Not surprisingly, 
the benzylpyrrole 12a was obtained in low yield (entry 18) due to the poor reactivity of alkyl-
diallylamines toward RCM reactions.21 It is well documented that tertiary amines inactivate GII 
forming stable complexes and thus preventing the RCM cyclization. On the other hand, the 
inactivation of GII by amines can be overcome if branched diallylamines are used as substrates. 
In fact, branched pyrroles 12e and 12g were obtained from the corresponding allylamines in 
good yields (entries 19-20).  
The attempt to obtain the pyrrole 12l via the chemoenzymatic cascade from the corresponding 
secondary amine was also unsuccessful (entry 21). An alternative route was thus developed 
(Scheme 2) leading to 12l in one-pot from the chloroethyl-carbamate 8. The carbamate 
protecting group allows the RCM reaction of 8 to take place almost instantaneously (around 20 
min) leading to the intermediate 13. The chloroethyl-carbamate protecting group is labile under 
the reaction conditions and it is slowly cleaved leading to pyrroline 9c. The latter is in turn 
oxidised by MAO-D5 affording the desired pyrrole 12l in 42% overall yield. Finally, the present 
methodology has been applied to the synthesis of a series of pyrrole analogues of the 
antitubercular agents recently described by us.2 As an example, the pyrroline 7b was converted 
in a single step into the pyrrole 14 by treatment with MAO-D5 followed by in situ Mannich 
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reaction with phenylpiperazine and formaldehyde. (Scheme 3). In addition, the pyrrole 12m,22 
precursor of the natural alkaloid myrmicarin217, was synthesised from the diene 6t via the 
chemoenzymatic method A in 20% isolated yield.23 (Scheme 3).  
CONCLUSIONS 
In conclusion, the aromatizing properties of MAO-N biocatalysts have been disclosed for the 
first time. MAO-N, and in particular the variant D5, catalyse the aromatization of a wide range 
of N-aryl- and N-alkyl-3-pyrrolines into the corresponding pyrroles. The ability of MAO-N 
biocatalysts to work in a concurrent way together with Grubbs’ catalyst has been also 
investigated leading to the development of a chemoenzymatic cascade reaction for the one pot 
synthesis of pyrroles from dilallyl-anilines and diallyl-amines. This work represents the first 
example of a chemoenzymatic cascade combining in the same reaction medium MAO-N with a 
metal-catalyst, other than boron reducing agents. The new methodology represents a robust and 
sustainable alternative to standard catalytic methods for the synthesis of pyrroles, which 
generally require the use of group specific or poorly available reagents, higher temperatures to 
promote the aromatization step and lead to the formation of several side products. Finally, the 
chemoenzymatic methodology is currently used in our laboratory for the synthesis of novel 










Figure 1. Classical RCM approaches for the synthesis of pyrroles and MAO-N 








Figure 2.Docking of pyrroline 7a into the MAO-D5 catalytic site and superposition of 7k on the 







































Table 1.  MAO-N and 6-HDNO aromatization of pyrrolines 7a-k 
 
3-Pyr. Ar R1 R2 R3 Biocat.a Pyrrole Conv (%)b 
     MAO-D5  61 
7a Ph H H H MAO-D9 11a 32 
     6-HDNO  60 
7b 4-F-Ph H H H MAO-D5 11b 60 
7c 4-Br-Ph H H H MAO-D5 11c 40 
     MAO-D5  >99 
7d 4-iPr-Ph H H H MAO-D9 11d 50 
     6-HDNO  27 
     MAO-D5  82 
7e 4-MeO-Ph H H H MAO-D9 11e 54 
     6-HDNO  21 
     MAO-D5  45 
7f 2,5-Me-Ph H H H MAO-D9 11f 34 
     6-HDNO  30 
7g 4-NO2-Ph H H H MAO-D5 11g 2 
7h 4-CN-Ph H H H MAO-D5 11h 2 
     MAO-D5  >99 
7i Ph H H Me MAO-D9 11i 51 
     6-HDNO  55 
     MAO-D5  0 
7j Ph Ph H H MAO-D9 11jc 0 
     6-HDNO  0 
7k Ph H H Ph MAO-D5 11kc 0 
     MAO-D9  0 
aFreeze-dried E.coli whole cells were used. bConversion values were measured by 
GC-MS spectroscopy and/or 1H-NMR. cPyrrolines 7j-k were also treated with 






Table 2.  MAO-N and 6-HDNO catalysed aromatization of pyrrolines 10a-h and 9 
 
3-Pyr. Alk R1 R2 R3 Biocat.a Pyrrole 
Conv 
(%)b 
     MAO-D5  >99 
10a Bn H H H MAO-D9 12a 61 
     6-HDNO  95 
10b 4-Cl-Bn H H H MAO-D5 12b 88 
10c  H H H MAO-D5 12c >99 
10d Isovaleryl H H H MAO-D5 12d >99 
10e  H H H MAO-D5 12e >99 
     MAO-D5  >99 
10f  H H H MAO-D9 12f 51 
     6-HDNO  65 
10g  H H H MAO-D5 12g 56 
10h  Me Me H MAO-D5 12h 48 
10i 4-Cl-Bn Me Me H MAO-D5 12i 51 
     MAO-D5  92 
10j Me H H Ph MAO-D9 12j 78 
     6-HDNO  87 
10k iPr H H Ph MAO-D5 12k 31 
     MAO-D5  33 
9c H H H Ph MAO-D9 12l 57 
     6-HDNO  10 
aFreeze-dried E.coli whole cells were used. bConversion values were 




Table 3. Optimization of the chemoenzymatic cascade 
 
Entry Co-Solvent Buffer/Cosolvent 
Ratio 6a/7a/11a 
(%)a 
1 DMF 60:1 90/10/0 
2 Acetone 60:1 10/90/0 
3 - 100:0 5/95/0 
4 DMSO 4:1 73/27/0 
5 DCM 4:1 75/25/0 
6 DMF 4:1 77/23/0 
7 THF 4:1 92/8/0 
8 Iso-octane 4:1 0/12/88 
aConversion values were measured both by GC-MS 













Entry Pyrrole R R1 Conv. (%)a Yield (%)b Method 
1 11a Ph H 88 78 A 
2 11a Ph H 95 65 B 
3 11b 4-F-Ph H 86 63 A 
4 11b 4-F-Ph H 99 59 B 
5 11c 4-Br-Ph H 15 10 B 
6 11d 4-iPr-Ph H 35 22 A 
7 11d 4-iPr-Ph H 75 70 B 
8 11e 4-MeO-Ph H 50 42 B 
9 11f 2,5-Me-Ph H 25 20 A 
10 11i Ph Me 87 45 B 
11 11l 4-Cl-Ph H 73 65 A 
12 11l 4-Cl-Ph H 90 56 B 
13 11m 4-Me-Ph H 99 50 A 
14 11m 4-Me-Ph H 90 45 B 
15 11n 2-MeO-Ph H 94 84 A 
16 11n 2-MeO-Ph H 81 72 B 
17 11o 3,4-(OCH2O)-Ph H 84 57 B 
18 12a Bn H 9 5 A & B 
19 12e 
 
H 63 41 B 
20 12g 
 
H 37 21 B 
21 12l H Ph 0 0 B 
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